Most secondary outcomes showed a trend in which patients with relapse in the IVIg withdrawal group had a larger difference compared to baseline compared to patients from the IVIg continuation group, Supplementary Table 3 shows deterioration on other outcome measures (grip strength, MRC sum score and the PGIC scale) in patients who reached a relapse end point on the different time points.
← all excerpts
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
1
—
—